| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash | 5,723,176 | 5,375,511 | 6,544,120 | |
| Investments in related entity | 125,000 | 994 | 994 | |
| Note receivable, net of premium | 105,711 | NaN | NaN | |
| Prepaids and other current assets | 105,032 | 35,036 | 87,593 | |
| Total current assets | 6,058,919 | 5,411,541 | 6,632,707 | |
| Other assets | 3,281 | 3,281 | 3,281 | |
| Licenses, net of amortization | 378,377 | 438,181 | 469,240 | |
| Total assets | 6,440,577 | 5,853,003 | 7,105,228 | |
| Accrued expenses | NaN | 0 | 0 | |
| Accounts payable | 293,455 | 247,159 | 263,450 | |
| Advances from related party | 14,194 | 14,194 | 14,194 | |
| Total current liabilities | 307,649 | 261,353 | 277,644 | |
| Total liabilities | 307,649 | 261,353 | 277,644 | |
| Common stock, 0.001 par value, 25,000,000 shares authorized 3,701,668 issued and 3,696,668 outstanding at march 31, 2026 and december 31, 2025, respectively | 3,144 | 2,586 | 2,586 | |
| Additional paid-in capital | 78,108,422 | 74,298,311 | 74,298,311 | |
| Accumulated deficit | -71,991,998 | -68,699,247 | -67,463,313 | |
| Treasury stock, at cost, 5,000 shares as of march 31, 2026 and december 31, 2025 | 10,000 | 10,000 | 10,000 | |
| Total stockholders' equity | 6,109,568 | 5,591,650 | 6,827,584 | |
| Non-controlling interest | 23,360 | NaN | NaN | |
| Total equity attributable to cmth | 6,132,928 | NaN | NaN | |
| Total liabilities and stockholders' equity | 6,440,577 | 5,853,003 | 7,105,228 | |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)